Story | Apr 20, 2011
A collection of news and information related to Bayer AG published by this site and its partners.
Top Bayer AG Articles see all
Displaying items 1-5
Story | Sep 30, 2013 | 6:30 AMSeveral categories of companies show promise for the second half of 2013. Among them are health care stocks, which offer investors a triple advantage. Many offer attractive yields; they're defensive holdings in an uncertain market; and the case for long-term growth is the best it has been in years. Drug companies have weathered a slew of patent expirations, and their pipelines are filling with potential blockbusters. Morningstar analyst Damien Conover recommends Sanofi (symbol SNY, $53), a Paris-based global giant that he says is well positioned in the diabetes market.
Story | Aug 28, 2014 | 6:42 AM
(Reuters) - OncoMed Pharmaceuticals Inc said the U.S. Food and Drug Administration lifted a partial hold on patient enrolments for three trials testing its experimental cancer drug, vantictumab. The drugmaker's stock rose as much 9 percent in early...
Story | Aug 17, 2014 | 2:39 PM
LOS ANGELES (Reuters) - Biotech drug production techniques based on plants, which may prove to be faster, higher yielding and cheaper than current methods using mammalian cells, haven't caught on with the biggest pharmaceutical companies. The leading...
Story | Aug 8, 2014 | 5:20 AM
MINNEAPOLIS Kristy Allen and Mark O'Rourke are bee ambassadors with deceptively similar messages. Allen, founder of a small business called the Beez Kneez, pedals through the Twin Cities selling honey from a bike trailer and handing out lawn signs that...